-
Diagnostics World | Watchmaker Genomics has launched TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. By capturing multiple biological dimensions in a single assay, TAPS+ delivers a richer, more comprehensive view of tumor biology, with the power to advance applications in translational oncology, early cancer detection, therapy response monitoring, fragmentomics, and minimal residual disease assessment.
Nov 19, 2025
-
Diagnostics World | The Association for Molecular Pathology hosted its 2025 Annual Meeting & Expo last week. Highlights from some of the research presented at the event include faster molecular tests for dangerous regional fungal infections, new Lyme disease tests, AI tools for improving molecular diagnosis, new use for old DNA samples to understand the evolution of colorectal cancer, and more.
Nov 18, 2025
-
Diagnostics World | In a study published this week in Nature, researchers from Illumina and The University of Queensland demonstrated the importance of whole-genome sequencing (WGS) to more fully capture the genetics underlying complex human traits and diseases.
Nov 14, 2025
-
Diagnostics World | Even though roughly two-thirds of pivotal studies leading to FDA drug approvals now enroll women at rates aligned with their disease burden, their inclusion has “plateaued." Diagnostic criteria and disease models remain largely male-centered because they don’t take into account of the biological and hormonal rhythms that shape women’s health across their lives. That diagnostic blind spot reverberates throughout drug development.
Nov 12, 2025
-
Diagnostics World | Veterans of Illumina and Grail launched Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease. Hepta emerged from stealth with $6.7 million in seed funding.
Nov 11, 2025
-
Diagnostics World | For most physicians, concerns about artificial intelligence (AI) continue to outweigh enthusiasm for its potential to improve healthcare decision-making and patient outcomes. Doctors need to understand the reasons behind the predictions of AI tools if they’re expected to use the insights as a starting point for discussing treatment options with their patients.
Nov 6, 2025
-
Diagnostics World | NHS England is trialing a 15-minute blood test that can distinguish between bacterial or viral infections, identifying serious diseases like sepsis or meningitis quickly in children. The study uses the MeMed BV test. From a small serum or venous whole blood sample, the test measures three host-response biomarkers—TRAIL, IP-10, and CRP.
Nov 4, 2025
-
Diagnostics World | When patients are prescribed drugs with a narrow therapeutic window, where the difference between an effective and toxic dose can be frighteningly small, therapeutic drug monitoring is crucial to their safety. Outside of a hospital setting with expensive lab equipment and specialized staff to do the monitoring, things can get dicey.
Oct 30, 2025
-
Diagnostics World | Pangaea launches its next-generation platform; EpiSign launches its Methylation-based Episignature Testing and Reference-based Interpretation & Classification (METRIC); Biodesix signs an expanded partnership agreement with Bio-Rad Laboratories; and more.
Oct 29, 2025
-
Diagnostics World | Kailera Therapeutics advances their obesity portfolio; Trogenix combines cancer cell killing and immune stimulation, delivered via a Trojan Horse approach that reawakens the immune system; and more.
Oct 28, 2025
-
Diagnostics World | Modern healthcare algorithms are trained with large volumes of data and can recognize patterns and correlate them with outcomes. However, there is still the issue of bias against underrepresented groups, even though these algorithms are trained using diverse populations. Researchers from the Icahn School of Medicine at Mount Sinai have developed AEquity, a tool of identification that reduces biases in datasets used to train machine learning algorithms.
Oct 24, 2025
-
Diagnostics World | Earlier this month, MyHeritage announced that they have upgraded their at-home DNA tests to have Whole Genome Sequencing. By utilizing Ultima Genomics’ sequencing technology and processing at the Gene by Gene lab, MyHeritage is the first major commercial DNA testing company to adopt Whole Genome Sequencing at such a massive scale of over one million tests per year.
Oct 22, 2025
-
Diagnostics World | A new diagnostic tool could soon help oncologists identify which tumors are most vulnerable to a class of immunotherapies that target cancer’s sugar-coated surface. Researchers at the UC Irvine School of Medicine have developed a companion diagnostic that measures glycan density in tumor tissue, which could redefine how solid tumors are detected, classified, and treated.
Oct 16, 2025
-
Diagnostics World | An innovative GPT model trained on vast amounts of anonymized data from healthy volunteers in the UK Biobank has been shown to be impressively good at predicting an individual’s risk of developing over 1,200 diseases over the next decade. Since the model represents disease risks as rates, it can also quantify how quickly new cases occur within a population over time.
Oct 15, 2025
-
Diagnostics World | As people with rheumatoid arthritis (RA) well know, it is a “forever disease” with no single magic-bullet cure or guarantee that they will ever feel like they did before their diagnosis. But a better understanding of what’s happening biologically before the first swollen joint appears could reveal opportunities to markedly modify the course of RA and, ultimately, prevent it.
Oct 14, 2025
-
Diagnostics World | There are more cases of cancer in the U.S. than ever before. Over 2 million new cases are expected to be diagnosed in 2025 alone, and cancer incidence is on the rise in 6 of the 10 most common cancers. Delivering speedy, accurate diagnoses and treatment for a growing pool of cancer patients is a daunting challenge for today’s clinicians.
Oct 10, 2025
-
Diagnostics World | We have entered a new era of science focused on developing tools and technologies to support early detection and diagnosis. The rapid evolution of research has led to the need to systematically collect, review, and distill findings into clear and actionable recommendations for how to use these tools in clinical practice
Oct 1, 2025
-
Diagnostics World | For patients with metastatic brain cancer, stereotactic radiosurgery has become an increasingly common treatment over the past decade based on the recommendations of medical physicists, guidelines of professional societies, and coverage guidelines of federal agencies. There has also been a change in the drugs used to treat the underlying cancer in conjunction with the procedure, especially in cases of metastatic cancer.
Sep 30, 2025
-
Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.
Sep 25, 2025
-
Diagnostics World | Mercy BioAnalytics will commercialize their blood-based ovarian cancer test portfolio; Cyted Health will accelerate the commercial expansion of their diagnostics platform in the U.S.; and more.
Sep 24, 2025